Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation

  • STATUS
    Recruiting
  • days left to enroll
    86
  • participants needed
    334
  • sponsor
    University Hospital, Basel, Switzerland
Updated on 28 October 2021
electrocardiogram
arrhythmia
fibrillation
cardioversion
12 lead ECG
electrophysiological study

Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. This study is to assess the heart rhythm device accuracy of five cardiac wearable devices (Apple Watch, Kardia Mobile/Kardia Mobile 6L, Fitbit Sense, Samsung Galaxy Watch 3 and Withings Scanwatch, Withings SA, Model Number: HWA09) and its detection algorithms in identifying AF compared to a nearly simultaneously acquired physician-interpreted 12-lead ECG in a real world cohort of patients.

Details
Condition Dysrhythmia, Arrhythmia, Atrial Fibrillation, Atrial Fibrillation (Pediatric)
Treatment cardiac wearable devices
Clinical Study IdentifierNCT04809922
SponsorUniversity Hospital, Basel, Switzerland
Last Modified on28 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

All consecutive patients undergoing electrophysiological study, pacemaker or implantable defibrillator (ICD) implantation or electric cardioversion at the University Hospital Basel are eligible for study participation and will be asked to participate

Exclusion Criteria

Use of a radial artery graft for coronary artery bypass grafting
Tattoos located on the skin of the wrist or forearm where wearable device will be placed
Patients receiving hemodialysis through arteriovenous fistula in the upper extremities
Patients with inability to communicate and comply with all study requirements
Patients who refused to participate in the trial
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note